Transcripta Bio raises $24.0M (United States, Jul 2026)
$24.0M
$24MGenerated social card
Headline
Transcripta Bio Raises $24M for AI Drug Discovery - AllSci
About
Transcripta Bio is an AI-driven drug discovery startup focused on developing small molecule therapeutics to modulate gene expression disease signatures. The company aims to advance IND-enabling studies and clinical preparation for neurological diseases, including autism spectrum disorder and muscular dystrophy. Their innovative approach leverages robotic platforms and AI models to enhance drug discovery success rates.
Article summary
Transcripta Bio Raises $24M for AI Drug Discovery AllSci
Founder
Chris Moxham
Founder & CEO
Investors · 4
2 hiddenRelated rounds
| Aug 14, 2026 | MiiHealth AI | $2.8M | — | United States |
| Aug 14, 2026 | Alloy Robotics | $8.0M | Pre-seed | United States |
| Aug 14, 2026 | Zipline | $950.0M | Debt | United States |
| Aug 14, 2026 | InduPro | $77.0M | Series B | United States |